In our opinion, EGFR immunohistochemistry can be reliably used for the detection of dispersed glioma cells; however, the assay must be calibrated for the purpose (positive immunoreactivity in membrane of trophoblastic cells and negative reaction with epidermis cells) and validated using at least several samples of glioses and gliomas. Here, EGFR is linked to central nervous system cancer.